HN analogs can also promote insulin secretion and glucose uptake by enhancing the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway and signaling molecules in fatty acid metabolism, reducing hepatic glucose production, offering new strategies for the treatment of diabetes (Wu et al., 2021). Here, AKT1 is linked to diabetes mellitus.